These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7691347)

  • 41. The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling.
    Shrimpton AE; McIntosh I; Brock DJ
    J Med Genet; 1991 May; 28(5):317-21. PubMed ID: 1713973
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of novel and rare mutations in exon 4 of the cystic fibrosis gene by SSCP.
    Shackleton S; Beards F; Harris A
    Hum Mol Genet; 1992 Sep; 1(6):439-40. PubMed ID: 1284529
    [No Abstract]   [Full Text] [Related]  

  • 43. Cystic fibrosis. Channelling our thoughts.
    Higgins CF; Hyde SC
    Nature; 1991 Jul; 352(6332):194-5. PubMed ID: 1713302
    [No Abstract]   [Full Text] [Related]  

  • 44. The cystic fibrosis transmembrane conductance regulator chloride channel. Iodide block and permeation.
    Tabcharani JA; Chang XB; Riordan JR; Hanrahan JW
    Biophys J; 1992 Apr; 62(1):1-4. PubMed ID: 1376160
    [No Abstract]   [Full Text] [Related]  

  • 45. Expression of the cystic fibrosis transmembrane conductance regulator gene in cells of non-epithelial origin.
    Yoshimura K; Nakamura H; Trapnell BC; Chu CS; Dalemans W; Pavirani A; Lecocq JP; Crystal RG
    Nucleic Acids Res; 1991 Oct; 19(19):5417-23. PubMed ID: 1717947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cystic fibrosis mice have arrived!
    Higgins CF; Trezise AE
    Hum Mol Genet; 1992 Oct; 1(7):459-60. PubMed ID: 1284887
    [No Abstract]   [Full Text] [Related]  

  • 47. Identification of a new frameshift mutation (3724 delG) in exon 19 of the CFTR gene.
    Bienvenu T; Lenoir G; Fonknechten N; Desclaux-Arramond F; Kaplan JC; Beldjord C
    Hum Mutat; 1994; 3(1):69-70. PubMed ID: 7509685
    [No Abstract]   [Full Text] [Related]  

  • 48. Monitoring for potential adverse effects of prenatal gene therapy: genotoxicity analysis in vitro and on small animal models ex vivo and in vivo.
    Themis M
    Methods Mol Biol; 2012; 891():341-70. PubMed ID: 22648780
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus.
    O'Neal WK; Hasty P; McCray PB; Casey B; Rivera-Pérez J; Welsh MJ; Beaudet AL; Bradley A
    Hum Mol Genet; 1993 Oct; 2(10):1561-9. PubMed ID: 7505691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel frame-shift mutation in exon 4 of the cystic fibrosis gene (435insA) demonstrates the ambiguity of restriction analysis for mutation screening.
    Kälin N; Dörk T; Bozon D; Tümmler B
    Hum Mol Genet; 1992 Oct; 1(7):545-6. PubMed ID: 1284889
    [No Abstract]   [Full Text] [Related]  

  • 51. Skipping of exon 9 in CFTR mRNA of human adult and fetal pancreas from non-CF individuals.
    Fonknechten N; Bienvenu T; Moriscot C; Beldjord C; Kahn A; Figarella C; Kaplan JC
    Hum Mol Genet; 1993 Dec; 2(12):2141-2. PubMed ID: 7509229
    [No Abstract]   [Full Text] [Related]  

  • 52. Prenatal diagnosis of cystic fibrosis in different European populations: application of denaturing gradient gel electrophoresis.
    Férec C; Verlingue C; Audrézet MP; Guillermit H; Quéré I; Raguenes O; Mercier B
    Fetal Diagn Ther; 1993; 8(5):341-50. PubMed ID: 7505587
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6.
    Siegel D; Irving NG; Friedman JM; Wainwright BJ
    Cytogenet Cell Genet; 1992; 61(3):184-5. PubMed ID: 1385049
    [No Abstract]   [Full Text] [Related]  

  • 54. A donor splice mutation (405 + 1 G-->A) in cystic fibrosis associated with exon skipping in epithelial CFTR mRNA.
    Dörk T; Will K; Demmer A; Tümmler B
    Hum Mol Genet; 1993 Nov; 2(11):1965-6. PubMed ID: 7506605
    [No Abstract]   [Full Text] [Related]  

  • 55. Optimal polymerase chain reaction amplification for preimplantation diagnosis in cystic fibrosis (delta F508).
    Cui KH; Haan EA; Wang LJ; Matthews CD
    BMJ; 1995 Aug; 311(7004):536-40. PubMed ID: 7545043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cystic fibrosis. Sickly channels in mild disease.
    Miller C
    Nature; 1993 Mar; 362(6416):106. PubMed ID: 7680767
    [No Abstract]   [Full Text] [Related]  

  • 57. Utility of internal markers to improve the accuracy of cystic fibrosis genotype analysis.
    Raskin S; Phillips JA; Vnencak-Jones C; Dawson E; Kaplan G; McClure M
    Biotechniques; 1992 Sep; 13(3):372-4. PubMed ID: 1382468
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe splice site mutation preceding exon 9 of the CFTR gene.
    Dörk T; Fislage R; Rappen U; Tümmler B
    Hum Mol Genet; 1993 Aug; 2(8):1313-4. PubMed ID: 7691349
    [No Abstract]   [Full Text] [Related]  

  • 59. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice.
    Clarke LL; Grubb BR; Yankaskas JR; Cotton CU; McKenzie A; Boucher RC
    Proc Natl Acad Sci U S A; 1994 Jan; 91(2):479-83. PubMed ID: 7507247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DNA hypomethylation leads to elevated mutation rates.
    Chen RZ; Pettersson U; Beard C; Jackson-Grusby L; Jaenisch R
    Nature; 1998 Sep; 395(6697):89-93. PubMed ID: 9738504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.